Clinical trial
Phase II Study as First Line Treatment for Patients With Advanced Non-Small Cell Lung Cancer
NCT00315185 is registered in ClinicalTrials.gov with Fox Chase Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study as First Line Treatment for Patients With Advanced Non-Small Cell Lung Cancer
- Lead sponsor
- Fox Chase Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2004
- Completion date
- June 30, 2008
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.